Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related BMY
The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut
Benzinga's Top Upgrades, Downgrades For December 6, 2018
Cancer Research Highlight: Curtains Begin To Close On AbbVie's Small Cell Program (Seeking Alpha)
Related HOG
Snapping Back, But Can Rally Attempt Last? Strong Earnings Might Power Market
A Peek Into The Markets: US Stock Futures Tumble Ahead Of Earnings

Analysts at Barclays downgraded Bristol-Myers Squibb Company (NYSE: BMY) from “overweight” to “equal-weight.” The target price for Bristol-Myers Squibb has been lowered from $65 to $46. Bristol-Myers Squibb's shares closed at $48.12 yesterday.

Analysts at Raymond James downgraded Harley-Davidson (NYSE: HOG) from “strong buy” to “market perform” and removed the price target of $84. Harley-Davidson's shares closed at $70.33 yesterday.

Baird downgraded U.S. Bancorp (NYSE: USB) from “outperform” to “neutral.” The price target for U.S. Bancorp is set to $44. U.S. Bancorp's shares closed at $43.34 yesterday.

Credit Suisse downgraded Hormel Foods (NYSE: HRL) from “outperform” to “neutral.” Hormel's shares closed at $49.19 yesterday.

Latest Ratings for BMY

DateFirmActionFromTo
Dec 2018BMO CapitalUpgradesMarket PerformOutperform
Nov 2018BMO CapitalMaintainsMarket PerformMarket Perform
Nov 2018Morgan StanleyMaintainsEqual-WeightEqual-Weight

View More Analyst Ratings for BMY
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BMY + HOG)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
BAPItau BBAUpgrades274.0
DVNJP MorganDowngrades37.0
EOGJP MorganUpgrades118.0
EQMBarclaysDowngrades48.0
EXPDGoldman SachsDowngrades68.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

UPDATE: Constellation Brands Posts Upbeat Q1 Earnings, Shares Surge

UPDATE: Keefe, Bruyette & Woods Downgrades Independent Bank As Focus Turns To Rebuilding Profitability